PET显像在内分泌肿瘤中的应用

袁志斌

PET显像在内分泌肿瘤中的应用

袁志斌

文章导航 > 国际放射医学核医学杂志 > 2003, 27 > 5: (208-211)

引用本文:

Citation:

PET显像在内分泌肿瘤中的应用

袁志斌^1,2

1. 200233 上海, 上海交通大学医学院;
2. 200233 上海, 上海市第六人民医院核医学科

作者简介: 袁志斌(1969-),男,副主任技师,主要从事放射性药物和核医学影像诊断的研究。;

中图分类号: R817.4

The application of PET in endocrine tumors

YUAN Zhi-bin^1,2

Department of Nuclear Medicine, Shanghai 6^th People's Hospital, Shanghai Jiaotong University, Shanghai 200233, China
CLC number: R817.4

摘要: PET显像在内分泌肿瘤中有着广泛的应用,包括甲状腺癌、甲状旁腺腺瘤、嗜铬细胞瘤和神经母细胞瘤等。在诊断内分泌肿瘤方面,与一些传统的核素显像方法相比较,PET显像未见明显的优势,但作为一种有益的补充手段,其临床价值已经得到认可。
- 正电子发射体层显像 /
- ¹⁸F-氟代脱氧葡萄糖 /
- 甲状腺癌 /
- 甲状旁腺腺瘤 /
- 嗜铬细胞瘤 /
- 神经母细胞瘤
Abstract: There are wide application of PET in endocrine tumors,including thyroid cancer,parathyroid adenoma,pheochromocytoma and neuroblastoma.Many papers concluded that in diagnosing endocrine tumors,PET does not show apparent advantages comparing with traditional radionuclide imaging methods.But as a useful complementary method,its clinical value has been recognized.
- positron emission tomography /
- ¹⁸F-fluorodeoxy-glucose /
- thyroid cancer /
- parathyroid adenoma /
- pheochromocytoma /
- neuroblastoma
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Diehl M,Risse JH,Brandt-MainzK,et al.Fluorine-18fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicenter study[J]. Eur J Nucl Med,2001,28(11): 1671-1676.
[2]	Moog F,Linke R,Manthey N,et al. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma[J]. J Nucl Med,2000, 41(12): 1989-1995.
[3]	Shiga T,Tsukamoto E,Nakada K,et al. Comparison of ¹⁸F-FDG,¹³¹I-Na,and ²⁰¹Tl in diagnosis of recurrent or metastatic thyroid carcinoma[J]. J Nucl Med,2001,42(3): 414-419.
[4]	Neumann DR,Esselstyn CB,MacIntyre WJ,et al. Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET[J]. Radiology,1994, 192(2): 509-512.
[5]	MelonP,Luxen A,Hamoir E,et al. Fluorine-18-fluorodeoxyglu-cose positron emission tomography fr preoperative parathyroid imaging in primary hyperparathyroidism[J]. Eur J Nucl Med, 1995, 22(6): 556-558.
[6]	Neumann DR, Esselstyn CB, MacIntyre WJ, et al. Compari-son of FDG-PET and seatamibi-SPECT in primary hyper-parathyroidism[J]. J Nucl Med,1996,37(11): 1809-1815.
[7]	Bergstrom M, Juhlin C, Bonasera TA, et al. PET imaging ofadrenal cortical tumors with the 11β-Hydroxylase tracer ¹¹C-Metomidate[J]. J Nucl Med,2000, 41(2): 275-282.
[8]	Shulkin BL, Thompson NW, Shapiro B, et al. Pheochromo-cytomas: imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glu-cose PET[J]. Radiology,1999, 212(7): 35-41.
[9]	Yun M,Kim W,Alnafisi N,et al. ¹⁸F-FDG PET in characterizing adrenal lesions detected on CT or MRI[J]. J Nucl Med,2001,42(12): 1795-1799.
[10]	Shulkin BL,Hutchinson RJ,Castle VP,et al. Neuroblas-toma: positron emission tomography with 2-[fluorine-18] fluoro-2-deoxy-D-glucose compared with metaiodobenzylguani-dine scintigraphy[J]. Radiology,1996, 199(3): 743-750.
[11]	Shulkin BL, Wieland DM, Baro ME, et al. PET hydrox-yphedrine imaging of neuroblastoma[J]. J Nucl Med, 1996, 37(1): 16-21.

[1]	华逢春 , 管一晖 , 赵军 . ¹⁸F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用. 国际放射医学核医学杂志, 2005, 29(5): 216-219,226.
[2]	吴湖炳 . ¹⁸F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值. 国际放射医学核医学杂志, 2005, 29(5): 205-209.
[3]	赵晋华 . ¹⁸F-FDG PET在淋巴瘤分期和治疗反应评价中的价值. 国际放射医学核医学杂志, 2004, 28(5): 210-212.
[4]	刘阳 , 王会祥 , 周涛 . 神经母细胞瘤股骨远端干骺端骨转移全身骨显像分析. 国际放射医学核医学杂志, 2012, 36(1): 27-29. doi: 10.3760/cma.j.issn.1673-4114.2012.01.007
[5]	刘建军 , 黄钢 . ¹⁸F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究. 国际放射医学核医学杂志, 2005, 29(5): 213-216.
[6]	蔡莉 , 李彦生 . 氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究. 国际放射医学核医学杂志, 2005, 29(1): 10-14.
[7]	姜磊 . 嗜铬细胞瘤的放射性核素诊断和治疗. 国际放射医学核医学杂志, 2008, 32(5): 278-281.
[8]	袁志斌 . 正电子肿瘤阳性显像剂¹⁸F-AMT. 国际放射医学核医学杂志, 2002, 26(5): 193-195.
[9]	张紫薇 , 程刚 . 放射性核素在嗜铬细胞瘤诊断与治疗中的应用进展. 国际放射医学核医学杂志, 2019, 43(1): 82-87. doi: 10.3760/cma.j.issn.1673-4114.2019.01.014
[10]	邵虹 . 神经母细胞瘤的影像学诊断. 国际放射医学核医学杂志, 2002, 26(4): 148-151.